Compare BFC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFC | VERA |
|---|---|---|
| Founded | 1894 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2021 |
| Metric | BFC | VERA |
|---|---|---|
| Price | $130.45 | $46.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $142.00 | $76.60 |
| AVG Volume (30 Days) | 53.7K | ★ 1.1M |
| Earning Date | 01-16-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.11 | N/A |
| Revenue | ★ $168,778,000.00 | N/A |
| Revenue This Year | $10.74 | N/A |
| Revenue Next Year | $59.30 | N/A |
| P/E Ratio | $18.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $93.00 | $18.53 |
| 52 Week High | $139.71 | $56.05 |
| Indicator | BFC | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 50.00 |
| Support Level | $121.77 | $45.02 |
| Resistance Level | $126.34 | $49.75 |
| Average True Range (ATR) | 3.28 | 2.51 |
| MACD | 0.58 | -0.98 |
| Stochastic Oscillator | 88.55 | 18.54 |
Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.